Integrating rule-based NLP and large language models for statin information extraction from clinical notes.

ABSTRACT:

Background

Identifying patient-specific barriers to statin therapy, such as intolerance or deferral, from clinical notes is a major challenge for improving cardiovascular care. Automating this process could enable targeted interventions and improve clinical decision support (CDS).

Objective

To develop and evaluate a novel hybrid artificial intelligence (AI) framework for accurately and efficiently extracting information on statin therapy barriers from large volumes of clinical notes.

Methods

The hybrid AI framework consisted of a rule-based natural language processing (NLP) filter, an LLM-based refinement filter, and an LLM-based multi-category classifier. The framework was developed on 2000 clinical notes and then retrospectively applied to a dataset of 197,761 notes from 47,192 patients at an academic medical center. Performance was evaluated against manual chart review for classifying statin intolerance, contraindications, and patient deferral.

Results

The framework was efficient, with the initial filter removing over 77 % of irrelevant notes while achieving a recall of 1.0 to ensure no relevant information was lost. The final classifier accurately categorized patient-level barriers with high F1 scores for intolerance (0.99), contraindications (0.81), and patient deferral (0.86). On the large dataset, the framework identified that 6.4 % of patients (n = 3,027) had documented intolerance, 0.7 % (n = 310) had contraindications, and 2.9 % (n = 1,391) had deferred therapy.

Conclusion

The hybrid AI framework provides an efficient, scalable, and trustworthy solution for processing clinical notes. It has the potential to enhance clinical decision support (CDS) systems by integrating detailed patient-level insights, improving adherence to clinical guidelines, and reducing provider burden. Future research should focus on implementing CDS tools that leverage extracted information to address barriers to statin therapy and optimize patient outcomes.

SUBMITTER: Liu S 

PROVIDER: S-EPMC12705237 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature